Medicover company profile
Company profile
Medicover has 49,000 employees and is headquartered in Stockholm, Sweden.
Dental care, outpatient clinics, mental health care and diagnostic laboratory tests are the services people most often associate with Medicover. The group provides healthcare and diagnostic services in Poland, Sweden and other markets. Its Healthcare Services segment covers outpatient and inpatient care, hospital care, orthopedics, preventive plans, sports and wellness, and benefit cards, while its Diagnostic Services segment covers tests such as microbiology, human genetics, haematology and histopathology. Its clients are corporate customers, individuals and public sector bodies.
In the fiscal year ended December 2025, revenue reached EUR 2.4 billion, up 13.7% on the previous year, and net income was EUR 77.5 million. The company, founded in 1995, is headquartered in Stockholm, Sweden, and employs 49,000 people. All figures are in euros.
Company facts
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- Country
- Sweden
- Headquarters
- Riddargatan 12A, 102 46, Stockholm
- Employees
- 49,000
- Chief executive
- John Stubbington
- Founded
- 1995
- Fiscal year
- January - December
- Listing
- MCOV.B · Nasdaq Stockholm
- Currency
- SEK
- ISIN
- SE0009778848
- Website
- medicover.com
Medicover and its competitors
The most similar companies by business and size
| Company | Country | Market cap | Employees | Operating margin | P/E (trailing 12 months) |
|---|---|---|---|---|---|
| MedicoverMCOV.B | Sweden | $3.82B | 49,000 | 7.4% | 38.3 |
| Fresenius Medical CareFME | Germany | $10.72B | 106,291 | 10.1% | 12.3 |
| Spire Healthcare GroupSPI | United Kingdom | $1.3B | 17,800 | 7.6% | — |
| TerveystaloTTALO | Finland | $830.61M | 8,111 | 8.9% | 13.0 |
| FreseniusFRE | Germany | $31.8B | 179,493 | 9.9% | 18.4 |
| Mouwasat Medical Services4002 | Saudi Arabia | $3.16B | 2,389 | 25.8% | 13.5 |
Competitors: same or related industry, same region first, then the closest market capitalization. Market cap converted into US dollars at the latest exchange rates; P/E over the last 12 months, not shown when negative.
